YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Curium to buy Lantheus in $8B deal

Posted online

Curium agreed to purchase radiopharmaceutical company Lantheus Holdings.

The deal is worth up to $8 billion.

Lantheus shareholders would receive $102.50 per share in cash when the deal closes. They would receive up to $12 more per share if certain sales targets are hit by 2030.

Read more from CNBC.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Fall 2026 Architects & Engineers Project Report

This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.

Most Read
Update cookies preferences